Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets ha...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2021-03-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1248.htm |
| _version_ | 1818326725495357440 |
|---|---|
| author | LIN Jian WANG Haibo SHEN Feng |
| author_facet | LIN Jian WANG Haibo SHEN Feng |
| author_sort | LIN Jian |
| collection | DOAJ |
| description | Intrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets have been found. This article will review the novel potential therapeutic targets of ICC. |
| first_indexed | 2024-12-13T12:04:56Z |
| format | Article |
| id | doaj.art-80fb895dfc274f1698c83af55269ba9d |
| institution | Directory Open Access Journal |
| issn | 1000-8578 1000-8578 |
| language | zho |
| last_indexed | 2024-12-13T12:04:56Z |
| publishDate | 2021-03-01 |
| publisher | Magazine House of Cancer Research on Prevention and Treatment |
| record_format | Article |
| series | Zhongliu Fangzhi Yanjiu |
| spelling | doaj.art-80fb895dfc274f1698c83af55269ba9d2022-12-21T23:46:59ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85781000-85782021-03-0148322422810.3971/j.issn.1000-8578.2021.20.12488578.2021.20.1248Advance in Therapeutic Targets of Intrahepatic CholangiocarcinomaLIN Jian0WANG Haibo1SHEN Feng2Department of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, ChinaDepartment of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, ChinaDepartment of Hepatic Surgery IV, The Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai 200433, ChinaIntrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets have been found. This article will review the novel potential therapeutic targets of ICC.http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1248.htmintrahepatic cholangiocarcinomatherapeutic targettumor microenvironmentnon-coding rnaepigenetic modifying enzyme |
| spellingShingle | LIN Jian WANG Haibo SHEN Feng Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma Zhongliu Fangzhi Yanjiu intrahepatic cholangiocarcinoma therapeutic target tumor microenvironment non-coding rna epigenetic modifying enzyme |
| title | Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma |
| title_full | Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma |
| title_fullStr | Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma |
| title_full_unstemmed | Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma |
| title_short | Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma |
| title_sort | advance in therapeutic targets of intrahepatic cholangiocarcinoma |
| topic | intrahepatic cholangiocarcinoma therapeutic target tumor microenvironment non-coding rna epigenetic modifying enzyme |
| url | http://html.rhhz.net/ZLFZYJ/html/8578.2021.20.1248.htm |
| work_keys_str_mv | AT linjian advanceintherapeutictargetsofintrahepaticcholangiocarcinoma AT wanghaibo advanceintherapeutictargetsofintrahepaticcholangiocarcinoma AT shenfeng advanceintherapeutictargetsofintrahepaticcholangiocarcinoma |